| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.9B | $1.8B | $1.7B | $1.6B | $1.4B | $1.5B | $1.5B | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | $1.3B | $1.2B | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $0.9B | $0.7B | $0.6B | $0.6B | $0.5B | $0.5B | $0.5B | $0.5B |
| Net Income | $0.7B | $0.8B | $0.4B | $0.4B | $0.5B | $0.6B | $0.1B | $0.4B |
| EPS (Basic) | $10.40 | $11.55 | $6.32 | $6.27 | $7.51 | $8.69 | $1.95 | $1.78 |
| EPS (Diluted) | $10.40 | $11.54 | $6.32 | $6.27 | $7.51 | $8.69 | $1.95 | $1.78 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $13.2B | $12.9B | $12.4B | $12.4B | $13.0B | $12.9B | $12.7B | $12.4B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $0.1B | $0.1B | $0.4B | $0.0B | $0.0B | $0.1B | $0.1B | $0.1B |
| Total Liabilities | $7.4B | $7.2B | $6.7B | $6.5B | $6.8B | $6.7B | $6.3B | $6.0B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $5.5B | $5.5B | $5.4B | $5.7B | $6.0B | $6.0B | $6.2B | $6.3B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.1B | $1.1B | $1.0B | $1.0B | $0.9B | $0.8B | $0.9B | $0.8B |
| Investing Cash Flow | $-0.6B | $-1.0B | $-0.1B | $0.1B | $-0.4B | $-0.4B | $-0.5B | $-0.1B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-0.5B | $-0.4B | $-0.5B | $-1.1B | $-0.5B | $-0.4B | $-0.5B | $-0.7B |